 |
|
Hypercoagulable States in Primary Upper-Extremity Deep Vein Thrombosis
Emmanuel Héron, MD;
Olivier Lozinguez, MD;
Martine Alhenc-Gelas, MD, PhD;
Joseph Emmerich, MD, PhD;
Jean-Noël Fiessinger, MD
Arch Intern Med. 2000;160:382-386.
Background There are very few data on the prevalence of coagulation abnormalities in primary deep vein thrombosis of the upper limbs.
Objective To determine if coagulation abnormalities play a role in effort-related and/or idiopathic (non–effort-related) upper-extremity deep vein thrombosis (UEDVT).
Methods Fifty-one consecutive patients (21 men and 30 women) who had effort-related (n = 20) or idiopathic (n = 31) UEDVT over an 18-year period (median age at diagnosis, 32 years; age range, 15-86 years) were routinely reexamined. Plasma was screened for antithrombin, protein C, and protein S deficiencies and for antiphospholipid antibodies (lupus anticoagulant and anticardiolipin antibodies). The DNA was screened for factor V Leiden and for prothrombin gene G20210A mutations.
Results The median age (35 vs 28 years), the proportion of women (81% [25/31] vs 25% [5/20]), the proportion of patients with a personal and/or family history of thromboembolism (42% [13/31] vs 15% [3/20]), and the proportion of patients with at least 1 coagulation abnormality (42% [13/31] vs 15% [3/20]) were higher in the idiopathic UEDVT group than in the effort-related UEDVT group. The odds ratio of having a coagulation abnormality was 4.09 (95% confidence interval, 0.99-16.78; P = .06) in the idiopathic UEDVT group compared with the effort-related UEDVT group.
Conclusion Hypercoagulable states appear to play a significant role in idiopathic but not in effort-related UEDVT.
From the Service de Médecine Vasculaire and Centre Claude Bernard de Recherche sur les Maladies Vasculaires Périphériques (Drs Héron, Lozinguez, Emmerich, and Fiessinger) and the Laboratoire d'Hémostase, Hôpital Broussais (Dr Alhenc-Gelas), Paris, France.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
How I treat rare venous thromboses
Martinelli et al.
Blood 2008;112:4818-4823.
ABSTRACT
| FULL TEXT
Recurrent Thrombosis and Survival After a First Venous Thrombosis of the Upper Extremity
Flinterman et al.
Circulation 2008;118:1366-1372.
ABSTRACT
| FULL TEXT
Diagnosis and Management of Subclavian Vein Thrombosis: Three Case Reports and Review of Literature
Smith and Dimitri
ANGIOLOGY 2008;59:100-106.
ABSTRACT
Prospective Evaluation of Combined Upper and Lower Extremity DVT
Hingorani et al.
VASC ENDOVASCULAR SURG 2006;40:131-134.
ABSTRACT
Morbidity and Mortality Associated with Internal Jugular Vein Thromboses
Ascher et al.
VASC ENDOVASCULAR SURG 2005;39:335-339.
ABSTRACT
An Integrative Review of Outcomes in Patients with Acute Primary Upper Extremity Deep Venous Thrombosis Following No Treatment or Treatment with Anticoagulation, Thrombolysis, or Surgical Algorithms
Thomas and Zierler
VASC ENDOVASCULAR SURG 2005;39:163-174.
ABSTRACT
Risk Factors and Recurrence Rate of Primary Deep Vein Thrombosis of the Upper Extremities
Martinelli et al.
Circulation 2004;110:566-570.
ABSTRACT
| FULL TEXT
Upper-Extremity Deep Vein Thrombosis
Joffe and Goldhaber
Circulation 2002;106:1874-1880.
FULL TEXT
Effort Thrombosis in the Elite Throwing Athlete
DiFelice et al.
Am J Sports Med 2002;30:708-712.
ABSTRACT
| FULL TEXT
Hypercoagulability Syndromes
Thomas
Arch Intern Med 2001;161:2433-2439.
ABSTRACT
| FULL TEXT
Thrombophilia
Caplin et al.
NEJM 2001;345:697-699.
FULL TEXT
Upper Extremity Deep Vein Thrombosis in a Young Patient Double Heterozygous for Factor V Leiden and Prothrombin G20210A Mutation
Vaya et al.
CLIN APPL THROMB HEMOST 2001;7:72-74.
ABSTRACT
|
